Home » Topics » Disease categories and therapies » Immune

Immune
RSS

New phase II/III trial for Dynavax ragweed allergy product

March 1, 2004

FDA agrees to dose range finding study for ISA-247

March 1, 2004

Effective prevention of viral ARI found with CVT-E002 in elderly subjects

Feb. 26, 2004

Potential use of CpG-7909 as a vaccine adjunct in HIV-infected patients

Feb. 19, 2004

FluMist reported to protect healthy children against natural influenza infection

Feb. 16, 2004

Sphingosine kinase type 2 involved in phosphorylation of immunosuppressant FTY-720

Feb. 16, 2004

Orphan drug status for Altastaph

Feb. 13, 2004

Myfortic completes European mutual recognition procedure

Feb. 13, 2004

Clinical benefits of topical tacrolimus in the treatment of skin disorders

Feb. 12, 2004

CellTech and Biogen Idec enter CD40L collaboration for autoimmune disease

Feb. 12, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 6, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
Neuracle eyes Shanghai IPO as global BCI funding surges
BioWorld
Neuracle Medical Technology Co. Ltd. is seeking a Shanghai IPO that could make it China’s first publicly listed invasive brain-computer interface (BCI) company,...